Amicus Therapeutics Series C

Amicus Therapeutics is a global biotechnology company focused on advancing therapies to treat rare diseases. As a wholly owned subsidiary of BioMarin Pharmaceutical Inc., it is guided by people living with rare diseases and aims to redefine expectations in this field. The company's website highlights its work in research and pipeline development, including clinical trials and expanded access programs for its medicines.